alpha-aminopyridine has been researched along with Diffuse Parenchymal Lung Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, Y; Goto, W; Hirakawa, K; Ishihara, S; Kashiwagi, S; Kawano, Y; Komoda, A; Morisaki, T; Noda, S; Ohira, M; Takashima, T; Tauchi, Y | 1 |
| Kashizaki, F; Sekido, Y; Tanaka, A | 1 |
| Asou, H; Chen, Y; Mori, S; Noma, S; Sakaguchi, S; Taguchi, Y; Takahashi, M; Tomii, K; Tsurutani, J | 1 |
| Goda, M; Ishizawa, K; Nawa, H; Niimura, T; Yagi, K; Zamami, Y | 1 |
4 other study(ies) available for alpha-aminopyridine and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
[A Case of Liver Abscess during Treatment for Abemaciclib-Induced Interstitial Lung Disease].
Topics: Aminopyridines; Benzimidazoles; Female; Humans; Liver Abscess; Lung Diseases, Interstitial; Middle Aged; Neoplasm Recurrence, Local | 2022 |
Efficacy of lorlatinib after alectinib-induced interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small cell lung cancer: a case report.
Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carbazoles; Carcinoma, Non-Small-Cell Lung; Humans; Kidney Diseases; Lactams; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles | 2022 |
Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Female; Humans; Japan; Lung Diseases, Interstitial; Middle Aged; Product Surveillance, Postmarketing; Tomography, X-Ray Computed | 2021 |
Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments.
Topics: Adult; Aged; Aminopyridines; Benzimidazoles; Databases, Factual; Female; Humans; Incidence; Japan; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyridines; Retrospective Studies | 2022 |